Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Aug 31, 2023 10:44am

177 Views

Post# 35613715

TLT treatment = the holy-grail of oncologist

- Only 2 treatments (much lower than competition)

- instant destruction of cancer cells

- sparring healthy cells

- no toxicity to patient

- high efficacy (higher than competition)

- treatment can be repeated, if needed

- standalone treatment

- not BCG dpende (unlike IMMUNITYBIO's N-803 used in combo with BCG and Keytruda)

- no patient discrimination based on genetic profile (unlike immunotherapy like Keytruda)

- suitable for immuno-suppresed and immuno-deficients (unlike FERRING's Adstiladrin gene therapy recently approved)

- easy to manufacture (small molecule = NDA. Less complex than BLA)

- Less expensive (still interesting profit margins)